ZyCoV-D, the world’s first DNA vaccine, will be deployed in seven Indian states in specific areas with low initial dose ranges. A vaccine made by Ahmedabad-based...
Dr. NK Arora, chair of the National Technical Advisory Group on Immunization (NTAGI), justified the government’s decision to postpone vaccination by three months after clinical recovery...
Delhi: Zydus Cadila has received an emergency use authorization from the Drugs Controller General of India (DGCI) for the use of “Vilafin” to treat moderate COVID-19...
New Delhi: On Friday, the Drugs Controller General of India (DGCI) granted urgent approval to Virafin, an antiviral drug for Zydus Cadila. The drug, pegylated interferon...
On Friday, the Drugs Controller General of India (DCGI) approved the emergency use of Virafin, an antiviral drug from Indian pharmaceutical company Zydus Cadila, for the...
Both companies are part of the non-profit drug patent pool (MPP). A coalition of 18 pharmaceutical companies in India, China, Bangladesh and South Africa that manufacture...
Recent Comments